by John A. Jenkins | Oct 15, 2026 | CPSC, FOIA, Law Firms, Litigation
As Discovery Deadline Looms, FOIA Request Seeks Crucial Evidence A four-month-old boy was put to sleep on his back in an Ingenuity Dream & Grow bassinet in August 2019. He was later found on his stomach. He died. In January 2022, a one-month-old girl...
by John A. Jenkins | Oct 8, 2026 | CPSC, FOIA, Law Firms, Litigation
FOIAengine: Before CPSC officials renewed a Casely charger warning, a personal-injury lawyer sought the records behind the recall. About 15 minutes into a flight from Wichita to Seattle, a passenger’s portable phone charger exploded. Leana Stickler was sitting beside...
by Randy Miller | Sep 24, 2026 | FDA, FOIA, Hedge Funds
FOIAengine: Sofinnova Bet on Drug FDA Approved Last Week Shares of Ultragenyx Pharmaceutical Inc. rose 16 percent September 17 after the Food and Drug Administration approved Fayuvi, its gene therapy for Sanfilippo syndrome Type A, a rare and devastating genetic...
by John A. Jenkins | Sep 9, 2026 | FOIA, Non-Profits, Politics
FOIAengine: Hundreds of Requests Targeted Biden Connections at Center for American Progress Months before Donald Trump threatened the Center for American Progress, the influential progressive policy organization, with a $5 billion defamation lawsuit,...
by John A. Jenkins | Sep 3, 2026 | FDA, FOIA
FOIAengine: Newly Remade Advisory Committee Green Lights Six Compounds, Despite the Applications Being Pulled Bobby Harshbarger is a Tennessee state senator and pharmacist of noteworthy lineage, with an interesting backstory. Both of his parents are...
by Randy Miller | Aug 20, 2026 | FDA, FOIA, News Media, Politics
FOIAengine: Twenty-One Requests from News Media, Non-Profits and Companies The nationwide outbreak of cyclospora infections this summer prompted a steady stream of national and local news articles, along with 21 Freedom of Information Act requests to the Food and Drug...
